Sign In to Request a Protocol
Sign In to Request a Protocol

SS-31 (50 mg Vial) Vitality Labs Protocol

  • Table of Contents

BPC-157 + TB-500 Dosage Chart

This BPC-157 + TB-500 blend information is provided for general research and educational reference only. For product-specific details, availability, or additional information, please contact us on Telegram. This content is not intended as medical advice, treatment guidance, or usage instruction.

  • Product Information: This blend is provided for general research and educational reference only. For product-specific details, preparation information, or availability, please contact us on Telegram.
  • Product Information: This blend is provided for general research and educational reference only. For product-specific details or availability, please contact us on Telegram.
  • Product Details: This information is provided for general research and educational reference only. For specific product details or availability, please contact us on Telegram.
  • Storage: Please follow the product label or packaging instructions for proper storage. For product-specific storage details, please contact us on Telegram.

BPC-157 + TB-500 blend information is provided for general research and educational reference only. This guide is intended to share general product information and should not be considered medical advice, treatment guidance, or usage instruction. For product-specific details or availability, please contact us on Telegram.

  • Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~6.67 mg/mL total)

Route: Subcutaneous injection | Frequency: Once daily

WeekDaily Dose (mcg)Units (per injection) (mL)
Weeks 1–2250 mcg (0.25 mg)10 units (0.10 mL)
Weeks 3–8500 mcg (0.50 mg)20 units (0.20 mL)
Weeks 9–12250 mcg (0.25 mg)10 units (0.10 mL)

For ≤10-unit (≤0.10 mL) administrations during Weeks 1–4, consider using 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  • 1 . Draw 3.0 mL bacteriostatic water with a sterile syringe.
  • 2 . Inject slowly down the vial wall; avoid foaming or direct stream onto the powder.
  • 3 . Gently swirl or roll until fully dissolved (do not shake).
  • 4 . Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Advanced / Loading Phase (Optional)

Some protocols use a higher TB-500 loading dose during the first 2–4 weeks based on clinical monograph recommendations. This schedule uses higher total blend volumes.

Route: Subcutaneous injection | Frequency: Once daily or split twice weekly for TB-500 loading

PhaseDaily Dose (total blend)Per-Peptide DoseUnits (mL)
Loading (Weeks 1–4)1,500 mcg (1.5 mg)~750 mcg each22.5 units (0.225 mL)
Maintenance (Weeks 5–8)1,000 mcg (1.0 mg)~500 mcg each15 units (0.15 mL)

Note: For additional product information, please contact us on Telegram.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

  • Product Details
  • Peptide Vials (BPC-157 + TB-500 20 mg Blend):
  • 4 weeks (28 doses at ~0.67–1.0 mg/day): 2 vials
  • 6 weeks (42 doses): 3 vials
  • 8 weeks (56 doses): 3–4 vials
  • Insulin Syringes (U-100):
  • Per week: 7 syringes (1/day)
  • 4 weeks: 28 syringes
  • 6 weeks: 42 syringes
  • 8 weeks: 56 syringes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
  • 4 weeks (2 vials): 6 mL → 1 × 10 mL bottle
  • 6 weeks (3 vials): 9 mL → 1 × 10 mL bottle
  • 8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.
  • Per week: 14 swabs (2/day)
  • 4 weeks: 56 swabs → recommend 1 × 100-count box
  • 6 weeks: 84 swabs → recommend 1 × 100-count box
  • 8 weeks: 112 swabs → recommend 2 × 100-count boxes
Contact Us
Contact Us
Contact Us
Contact Us
  • Protocol Overview

Concise summary of the once-daily regimen.

  • Goal: Support tissue repair, wound healing, and musculoskeletal recovery in research contexts[1][3].
  • Schedule: Daily subcutaneous injections for 4–8 weeks; some protocols include 3-month-on / 6-week-off cycling.
  • Dose Range: 500–1,500 mcg total blend daily (providing ~250–750 mcg of each peptide).
  • Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL total) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; use within 14 days[6].
  • Dosing Protocol

Suggested daily titration approach.

  • Start: 500–666 mcg total blend daily (~250–333 mcg each peptide).
  • Target: 1,000 mcg total blend daily (~500 mcg each) by Weeks 3–8.
  • Frequency: Once per day (subcutaneous).
  • Cycle Length: 4–8 weeks; optional cycling with 6-week breaks between courses.
  • Timing: Any consistent time; some prefer morning administration; rotate injection sites.
  • Storage Instructions

Proper storage preserves peptide quality and stability.

  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[6].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 14 days and avoid freeze-thaw cycles[7].
  • Allow vials to reach room temperature before opening to reduce condensation uptake.
  • Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each injection; dispose properly in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and maintain absorption[8].
  • Inject near the site of injury when targeting localized tissue repair (within anatomical reason).
  • Document daily dose and site rotation to maintain consistency.
  • Both BPC-157 and TB-500 are prohibited in competitive sports by WADA[9].
  • How This Works

BPC-157 is a synthetic pentadecapeptide (15 amino acids) originally isolated from human gastric juice. Preclinical research indicates it exerts cytoprotective effects across multiple organ systems, promotes angiogenesis, modulates nitric oxide pathways, and interacts with growth-factor systems involved in tissue repair. TB-500 (Thymosin β4) is a naturally occurring peptide that regulates actin polymerization, promotes cell migration, reduces inflammation, and supports wound healing and tissue regeneration[3][4]. The combination is hypothesized to provide complementary mechanisms for accelerated musculoskeletal and soft-tissue recovery.

  • Potential Benefits & Side Effects

Observations from preclinical and early clinical literature.

  • Tissue Repair: Both peptides demonstrate wound-healing, tendon-repair, and anti-inflammatory properties in animal models[1][3][10].
  • Gastrointestinal Support: BPC-157 shows gastroprotective and ulcer-healing effects in preclinical studies[2].
  • Safety Profile: Preclinical data indicate a wide safety margin for BPC-157 (no lethal dose up to ~20 mg/kg); TB-500 human tolerability studies report mild adverse events at doses up to 1,260 mg[5][11].
  • Possible Side Effects: Occasional mild injection-site reactions (redness, itching); rare reports of transient dizziness or nausea; long-term human safety data remain limited.
  • Lifestyle Factors

Complementary strategies for best outcomes.

  • Prioritize adequate protein intake to support tissue synthesis and repair.
  • Combine with appropriate rehabilitation protocols when addressing musculoskeletal injuries.
  • Ensure quality sleep and stress management to optimize recovery and healing responses.
  • Stay hydrated and maintain balanced micronutrient intake (vitamins C, D, zinc) to support connective-tissue health.
  • Injection Technique

General subcutaneous guidance from clinical best-practice resources.

  • Clean the vial stopper and injection site with alcohol; allow to dry completely.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue (use 23–25 gauge, 5/8″ needle)[12][13].
  • Aspiration is unnecessary for subcutaneous injections; inject slowly and steadily[12].
  • Rotate sites systematically (abdomen, lateral thigh, upper arm, buttocks) to avoid lipohypertrophy[8].
  • For localized injuries, inject subcutaneously near (not into) the affected area when anatomically appropriate.
  • Recommended Source

We recommend Vitality Labs Blueprint Peptides for high-purity BPC-157 + TB-500 (10 mg blend).

Why Vitality Labs Blueprint Peptides?

  • High-purity, third-party-tested lots with batch COAs.
  • Consistent, ISO-aligned handling and documentation.
  • Reliable fulfillment to maintain cold-chain integrity.
Contact on Telegram
  • Important Note

This content is for educational purposes only and is not medical advice.

  • References

Explore related research dosage protocols and background reading for BPC-157 + TB-500.

PubMed

— Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds
More Info

Current Pharmaceutical Design (PubMed)

— Stable gastric pentadecapeptide BPC-157: novel therapy in gastrointestinal tract
More Info

PMC

— Utilizing developmentally essential secreted peptides such as Thymosin Beta-4 for regenerative therapies
More Info

Annals of the New York Academy of Sciences (PubMed)

— Thymosin beta 4 and wound healing: new ideas
More Info

PMC

— Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review
More Info

Johns Hopkins Arthritis Center

— How to give a subcutaneous injection
More Info

PMC

— Subcutaneous drug delivery review: pharmacologic considerations
More Info

ASIPP / Alternative Therapies in Health and Medicine

— Intra-articular injection of BPC-157 for multiple types of knee pain
More Info

A4M

— Thymosin Beta-4 professional monograph
More Info

PubMed

— Detection of thymosin beta-4 and related peptides in sport drug testing
More Info

Journal of Physiology and Pharmacology (PubMed)

— BPC-157 activity at very low doses without toxicity in animal studies
More Info

Expert Opinion on Biological Therapy (PubMed)

— Thymosin beta-4 and its role in wound healing
More Info

CDC

— Vaccine administration: subcutaneous route (angle/site; no aspiration)
More Info

NCBI Bookshelf

— Best practices for injection (asepsis, preparation, and administration)
More Info

Contact on Telegram Peptides

— BPC-157 + TB-500 (10 mg blend) product page (quality and batch documentation)
More Info